Glanders
APHA is a National reference laboratory for Glanders which is a contagious zoonotic bacterial disease, predominantly affecting horses, mules and donkeys. Glanders is caused by the bacterium Burkholderia mallei.
Glanders is endemic in Africa, Asia, the Middle East, and Central and South America. It has been eradicated from North America, Australia, and most of Europe through surveillance and destruction of affected animals, and import restrictions. Glanders is classified as an exotic notifiable disease in the UK, which means any suspected case must be reported to APHA by law.
Due to similar clinical features to other diseases, such as Strangles, EVA, Fungal Pneumonia, Ulcerative Lymphangitis, Pseudotuberculosis, Epizootic Lymphangitis, diagnosis of Glanders would need be confirmed by serological assay and/or specific identification of the causative agent.
The Complement Fixation Test (CFT) for Glanders is currently the only World Organisation for Animal Health (OIE) prescribed serodiagnostic method for international trade purposes and is also recommended for surveillance investigations.
Our Glanders reagents are manufactured in a dedicated Production Unit certified to ISO 9001 quality standards, and supported by expert veterinarians in our reference laboratory. To ensure consistency across different CFT kits, our products are tested against 2 common CFT antigens. For safety considerations, those antisera were raised using non-infectious materials. We recommend the use of both high and low titre positive serum to ensure sensitivity and consistency of CFT tests.
To support your laboratory with testing APHA Scientific offer the following control reagents:
RAB8678 – Glanders Equine High Positive Antiserum
Equine sera positive to Burkholderia mallei by Glanders complement fixation test. This antiserum is to be used as a high titre positive control antiserum for the Glanders CFT.
RAB8677 – Glanders Equine Low Positive Antiserum
Equine sera positive to Burkholderia mallei by Glanders complement fixation test. This antiserum is to be used as a low titre positive control antiserum for the Glanders CFT.
RAB8676 – Glanders Equine Negative Sera
Equine sera negative to Burkholderia mallei by the Glanders complement fixation test.
- Extensive expertise
- Excellent specialist facilities
- A comprehensive and quality delivery service
Welcome to Our New APHA Scientific Website
We’re excited to share our new and improved APHA Scientific website. This project reflects our commitment to providing a more modern, accessible, and user-friendly platform to our global commercial customer base.
APHA Scientific at WAVLD 2025: Advancing Veterinary Diagnostics Together
We were pleased to attend the World Association of Veterinary Laboratory Diagnosticians (WAVLD) 2025 conference in Calgary, Canada, as a Silver Sponsor.
APHA Scientific – Launch of PT-LIMS: Our New Laboratory Information Management System
We’re excited to announce the launch of PT-LIMS, our improved Proficiency Testing Laboratory Information Management System, now live for all registered customers.
New price Lists Available for 2025–2026 Proficiency Testing Schemes & Biological Reagents
We’re pleased to announce the release of our updated price lists for the 2025–2026 contract year.
VETQAS Terms and Conditions (T&Cs)
We want to let you know that our VETQAS T&Cs have recently been updated to reflect changes in business practices and legal requirements.
APHA Scientific – Successful Accreditation Visit and Transition to New ISO Standard
In February, VETQAS welcomed assessors for our annual UKAS accreditation visit, a vital part of maintaining our high standards and commitment to quality.
VETQAS Proficiency Testing – Help Us Improve with Our Customer Survey
VETQAS Proficiency Testing are always looking for ways to improve our services, and your feedback plays a crucial role in helping us achieve that goal.
APHA Scientific attending AAVLD 2024
APHA Scientific business development team is exhibiting at the American Association of Veterinary Laboratory Diagnosticians annual meeting which takes place on October 12 – 13, 2024 at Gaylord Opryland Resort & Convention Center in Nashville, USA.